PRO-PHARMACEUTICALS, INC. 8-K

Company

GALECTIN THERAPEUTICS INC

Filed

May 8, 2006

Period of Report

May 8, 2006

Accession Number

0001157523-06-004772

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →